Get started
Work

Subcutaneously Administered Recombinant Human Interleukin-2 and Interferon Alfa-2a for Advanced Breast Cancer: A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)

Year: 2003
Type: article
Study design: Clinical Trial
DOI: 10.1023/b:drug.0000006178.32718.22
Authors: Gretchen Kimmick, Mark J. Ratain, Don Berry, Susan Woolf, Larry Norton, Hyman B. Muss
Institutions: Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, Wake Forest University, University of Chicago, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, University of Vermont
Language: English
Subfield: Cancer Research
Open Access status: closed
Awards: G10814802, G2045835003, CANCER AND LEUKEMIA GROUP B, G220937036, G237383067, North Shore CCOP, G257334932, G260759372, Cancer and Leukemia Group B, G2647518335, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B--MOUNT SINAI, Cancer and Leukemia Group B, G4192246825, G436504642, G4530377164, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Cancer and Leukemia Group B, G802218729, CANCER AND LEUKEMIA GROUP B, G877907214, G926666752, G973482110
OpenAlex ID: W1999976969
FWCI: 0.124
Cites: 31
Cited by: 14
Related to: 10